Mon, Nov 24, 2014, 3:23 AM EST - U.S. Markets open in 6 hrs 7 mins

Recent

% | $
Quotes you view appear here for quick access.

CHINA KANGTAI CACTUS Message Board

  • bestareahead bestareahead Apr 19, 2011 4:49 PM Flag

    NEW deal with the funds (Kodiak)

    The fund Kodiak keeps investing in CKGT !News are out today.
    They keep trusting the mgmt,the products, the strategy.


    They invested less than 1 million $ back in 2009.
    Now they invest much more than that.


    Their continuing investments and dd on CKGT strengthens the current retail holders's trust to the company.glta.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Why can't I post here? Test

    • But why do they need $1.5 million when they have $7.4 million on accounts receivables. Why not just get on the phone and tell some of them to pay their bill!

    • I agree that this is more positive than negative. The small dilution doesn't matter since we are selling at 1x earnings, so we go to 1.2 times earnings. Big deal!
      The confidence of the investors in the company is worth much more. If it goes down to .30, as some have claimed, I'm buying.

    • 1) The growth CKGT experienced last year deserved the first cash injection/placement from Kodiak.Growth yoy was phenomenal in 2010.


      So the SUPPOSEDLY longs do not need to dislike the SINGLE digit % dilution after the second Kodiak placement.CKGT will prove in 2011 again that it is worth it.


      2) This second placement is an other sign of trust and due diligence on CKGT.I can tell you the Kodiak managers have gone more than twice at CKGT facilities during the last 10 months.

      • 3 Replies to bestareahead
      • Your thinking is absurd.
        1) The growth CKGT experienced last year deserved the first cash injection/placement from Kodiak.Growth yoy was phenomenal in 2010.

        It has been 30-35% growth for 5 years. They did not get the money from Kodiak until Nov. of 2010.

        "This second placement is an other sign of trust and due diligence on CKGT.I can tell you the Kodiak managers have gone more than twice at CKGT facilities during the last 10 months."

        How in Hell is trust involved. They got the shares for a 15% discount and dumped on Dec. PR's

        Obviously you are clueless and management is using US shareholders as a personal piggyback.

        Bookvalue is over $2.00 a share. If you had a house appraised at $100K would you sell it for $25k? Knowing you had $2.6 Mil in the bank and over $7 mil in A/R.

        This may not be 100% fraud but you can bet your butt fraud is being committed against US shareholders. NO management would do this with the purported Blance Sheet CKGT claims to have...and to think management has all these shares.

      • "I can tell you the Kodiak managers have gone more than twice at CKGT facilities during the last 10 months"

        How can I verify your claim? Have a link, phone number, contact person?

        TIA

      • The growth and the audited 2010 results along with the Kodiak past placement are below.


        fyi,Kodiak bought at 0,79 $ the shares of CKGT last year.

        "The Company received net proceeds from Kodiak of $742,678 ($784,678 gross based on a price of $0.79 per share, less $42,000 fees and costs charged by Kodiak). The proceeds will be used to maintain the financial liquidity of the cigarette factory in Macao."

        “Cactus cigarette products opened enormous opportunities for our company in 2010 and we have great expectations for the future. We expect our agreements with both China Tobacco Shandong and Shandong Yishui Ruibosi will stimulate cigarette revenue to new levels this year and further broaden shareholder value,” Mr. Wang said.



        HARBIN, China--(BUSINESS WIRE)--China Kangtai Cactus Biotech Inc. (OTCBB: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announced today that 2010 revenue increased 36% to $36 million, compared to $26.5 million in 2009. Net income for 2010 increased to $11.8 million or $0.56 per diluted share compared to net income of $0.48 million for 2009, or $0.02 per diluted share. The Company’s 2009 net income was impacted by the reclassification of outstanding Series A Preferred Stock and A, B, C and D warrants from stockholders’ equity to liabilities at fair value.



        Full Year Financial Highlights:

        Revenue in 2010 increased 36% to $36 million, up from $26.5 million recorded in 2009
        Net income rose 2,356% to $11.8 million or $0.56 per diluted share versus $480,125 or $0.02 per diluted share in 2009
        Adjusted net income (excluding the reclassification of Series A Preferred Stock and A, B, C and D warrants) rose 13% to $7.3 million or $0.35 per diluted share versus $6.5 million or $0.33 per diluted share in 2009
        Gross profit margin was 38% compared to 40% in 2009
        Income from operations increased 19% to $11.3 million from $9.5 million in 2009.


        Full Year Product Categories Performance:

        Sales of cactus cigarettes increased 818% to $2.9 million, from $317,133 recorded in the same period of 2009
        Cactus feed sales increased 99% to $4.6 million, up from $2.3 million recorded in the same period of 2009
        Beverage sales increased 35% to $12.6 million, up from $9.3 million recorded in the same period of 2009
        Raw & intermediate material sales decreased 15% to $2.9 million from $3.5 million recorded in the same period of 2009
        Nutraceutical sales revenue increased 21% to $13 million, up from $10.7 million in the same period of 2009
        Packaged foods provided no revenue in 2010, compared to $384,337 in the same period of 2009.

 
CKGT
0.0130.000(0.00%)Jul 28 8:10 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.